Page last updated: 2024-08-25

rosiglitazone and gw 9578

rosiglitazone has been researched along with gw 9578 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM1
Chung, HK; Dong Koo, K; Ho Woo, S; Hur, GC; Joo Yim, H; Kim, GT; Kim, KH; Kim, SH; Lee, CS; Oon Han, H; Sung Koh, J1
Chen, X; Cryan, E; Demarest, KT; Hlasta, DJ; Matthews, JM; Rybczynski, PJ; Strauss, K; Tang, Y; Xu, JZ; Yang, M; Zhou, L1
de Lera, AR; Otero, MP; Pérez Santín, E; Rodríguez-Barrios, F; Vaz, B1
Baatjes, AJ; Campbell, H; Dua, B; Gauvreau, GM; Hill, M; Howie, K; Oliveria, JP; Sehmi, R; Smith, SG; Watson, BM; Watson, RM1

Reviews

1 review(s) available for rosiglitazone and gw 9578

ArticleYear
The PPARs: from orphan receptors to drug discovery.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2000

Other Studies

4 other study(ies) available for rosiglitazone and gw 9578

ArticleYear
Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
    Bioorganic & medicinal chemistry letters, 2007, Feb-15, Volume: 17, Issue:4

    Topics: Animals; Area Under Curve; Biological Availability; Blood Glucose; Cell Line, Tumor; Drug Design; Humans; Hypoglycemic Agents; Indicators and Reagents; Lipids; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Molecular; Phenylpropionates; PPAR alpha; PPAR gamma; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Triglycerides

2007
Design and synthesis of indane-ureido-thioisobutyric acids: A novel class of PPARalpha agonists.
    Bioorganic & medicinal chemistry letters, 2007, Dec-15, Volume: 17, Issue:24

    Topics: Amino Acids; Animals; Butyrates; Combinatorial Chemistry Techniques; Drug Design; Humans; Indans; Mice; Mice, Inbred Strains; Molecular Structure; PPAR alpha; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Urea

2007
Selective, potent PPARgamma agonists with cyclopentenone core structure.
    Bioorganic & medicinal chemistry letters, 2009, Apr-01, Volume: 19, Issue:7

    Topics: Cell Line; Computer Simulation; Cyclopentanes; HeLa Cells; Humans; PPAR gamma; Structure-Activity Relationship

2009
Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation.
    Immunology, 2014, Volume: 142, Issue:3

    Topics: Adolescent; Adult; Aged; Butyrates; Cell Differentiation; Dose-Response Relationship, Drug; Eosinophils; Female; Humans; Interleukin-5; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Young Adult

2014